WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 13'3401 Infant (under 12 months) mortality rate: 682
GDP / capita (US$): 32'2671 Child (under 5 years) mortality rate: 942

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 845  821  797  774  751  531  377  221 
Births 29  29  28  28  27  21  18 
Surviving infants 27  27  26  26  25  19  16 
Pop. less than 5 years 128  125  123  120  117  88  69  30 
Pop. less than 15 years 332  324  316  308  300  228  143  97 
Female 15-49 years 194  189  184  180  175  121  90  44 

Number of reported cases

(Click for retrospective incidence data for Equatorial Guinea)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  1'250  13  321  1'190  32 
Mumps
ChartChart
 
Pertussis
ChartChart
  67 
Polio*
ChartChart
 
Rubella
ChartChart
  14 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Equatorial Guinea)
Vaccine year result method % card seen                                                
BCG 2010  71  DHS   37  35  64  51  53  53  34 
DTP1 2010  59  DHS   37  26  57  47  54  42  39 
DTP3 2010  41  DHS   37  17  45  24  41  54  32 
DTP4         
IPV1         
HepB_BD         
HepB3          17  45 
Hib3          17  45 
JapEnc         
MCV1          26  43  41  34  50  19 
MCV2         
PCV1         
PCV3         
Pol3 2010  34  DHS   37  27  52  40  40  53  32 
Rota1         
RotaC         
Rubella1         
TT2plus 2010  63  DHS   37  23  36  31  30  64  30 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Equatorial Guinea)
BCG
ChartChart
  48  56  64  66  66  73  94 
DTP1
ChartChart
  28  59  49  56  59  64  96 
DTP3
ChartChart
  16  20  24  41  34  77 
HepB3
ChartChart
  16  20 
HepB_BD
ChartChart
 
Hib3
ChartChart
  16  20 
IPV1
ChartChart
 
MCV1
ChartChart
  27  44  42  35  51  51  88 
MCV2
ChartChart
 
PAB
ChartChart
  70  70  75  75  75  61  58 
PCV3
ChartChart
 
Pol3
ChartChart
  17  24  30  30  39  41  75 
RCV1
ChartChart
 
RotaC
ChartChart
 
YFV
ChartChart
 

Number of districts in the country 18  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 6
Less than 50% 94
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes From April 2016
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 years; Yes
VitaminA 6, 12 months; Yes
YF 9 months; Yes From August 2016

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   NA  2009-2013  2009-2013  2009-2013  2009-2013  2009-2013 
Nº of districts with microplans that include activities to raise immunization coverage number 18  18  18  16  18 

System performance

Total Nº districts in country number 18  18  18  18  18  18  18 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 11  17  22 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 11  22 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No  No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  80  100  100  59  74 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.